A Phase 2/3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study of Mitapivat in Patients with Sickle Cell Disease: RISE UP Phase 2 Results

被引：2

作者：

Idowu, Modupe ^{[1
]}

Otieno, Lucas ^{[2
]}

Dumitriu, Bogdan ^{[3
]}

Lobo, Clarisse L. C. ^{[4
]}

Thein, Swee Lay ^{[5
]}

Andemariam, Biree ^{[6
]}

Nnodu, Obiageli E. ^{[7
]}

Inati, Adlette ^{[8
]}

Glaros, Alexander K. ^{[9
]}

Olalla Saad, Sara Teresinha ^{[10
,11
]}

Bartolucci, Pablo ^{[12
]}

Colombatti, Raffaella ^{[13
]}

Taher, Ali T. ^{[14
]}

Abboud, Miguel R. ^{[15
]}

Oluyadi, Abdulafeez ^{[16
]}

Iyer, Varsha ^{[16
]}

Yin, Ophelia ^{[17
,18
]}

Morris, Susan ^{[16
]}

Yates, Amber M. ^{[16
]}

Shao, Hui ^{[16
]}

Patil, Spurthi ^{[16
]}

Urbstonaitis, Rolandas ^{[16
]}

Zaidi, Ahmar U. ^{[16
]}

Smith, Wally R. ^{[19
]}

机构：

[1] UTHealth, McGovern Med Sch, Houston, TX USA

[2] Victoria Biomed Res Inst, Kisumu, Kenya

[3] Mid Atlantic Permanente Med Grp, Largo, MD USA

[4] HEMORIO, Div Res, Rio De Janeiro, Brazil

[5] NHLBI, Sickle Cell Branch, Bethesda, MD USA

[6] Univ Connecticut Hlth, New England Sickle Cell Inst, Farmington, CT USA

[7] Univ Abuja, Dept Haematol & Blood Transfus, Coll Hlth Sci, Ctr Excellence Sickle Cell Dis Res & Training, Abuja, Nigeria

[8] Lebanese Amer Univ, Gilbert & Rose Marie Chagoury Sch Med, Byblos & NINI Hosp, Tripoli, Lebanon

[9] Childrens Hosp Michigan, Div Hematol Oncol, Detroit, MI USA

[10] Univ Estadual Campinas, Hematol & Transfus Med Ctr, Hemoctr, Campinas, SP, Brazil

[11] Univ Campinas Unicamp, Campinas, Brazil

[12] Mondor Univ Hosp, Reference Ctr Sickle Cell Dis, Creteil, France

[13] Univ Padua, Pediat Hematol Oncol Unit, Padua, Italy

[14] Amer Univ Beirut, Med Ctr, Beirut, Lebanon

[15] Amer Univ, Dept Pediat & Adolescent Med, Beirut Med Ctr, Beirut, Lebanon

[16] Agios Pharmaceut Inc, Cambridge, MA USA

[17] ITeos Therapeut, Watertown, MA USA

[18] Agios Pharmaceut Inc, Time Res, Cambridge, MA USA

[19] Virginia Commonwealth Univ, Richmond, VA USA

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-187033

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：6

共 50 条

[41] Doxycycline in Creutzfeldt-Jakob disease: A phase 2, randomized, double-blind, placebo-controlled trial
Brandel, Jean-Philippe
Marcon, Gabriella
Coudert, Mathieu
Tettamanti, Mauro
Welaratne, Arlette
Giacone, Georgio
Azimi, Shohreh
Pietrini, Vladimiro
Fabreguettes, Jean-Roch
Imperiale, Daniele
Aucan, Christophe
Lucca, Ugo
Mallet, Alain
Salmona, Mario
Zerr, Inga
Redaelli, Veronica
Forloni, Gianluigi
Haik, Stephane
Tagliavini, Fabrizio
PRION, 2013, 7 : 62 - 62
[42] Talactoferrin Alfa Reduces Mortality In Severe Sepsis: Results Of A Phase 2 Randomized, Placebo-controlled, Double-blind Study
Guntupalli, K. K.
Dean, N. C.
Morris, P. E.
Bandi, V.
Margolis, B. D.
Rivers, E.
Levy, M. M.
Lodato, R. F.
Schaumberg, J.
Malik, R. K.
Dellinger, P.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
[43] Safety and tolerability of twice-daily balsalazide tablets: Results of a phase 3, randomized, double-blind, placebo-controlled, multicenter study
Pruitt, Ronald E.
Rosen, Alan A.
Wruble, Lawrence
Sedghi, Shahriar
Shepard, Roland D.
Mareya, Shadreck M.
Huang, Shirley
Shaw, Audrey L.
Forbes, William F.
GASTROENTEROLOGY, 2008, 134 (04) : A494 - A494
[44] Tolvaptan for improvement of hepatic edema: A phase 3, multicenter, randomized, double-blind, placebo-controlled trial
Sakaida, Isao
Kawazoe, Seiji
Kajimura, Kozo
Saito, Takafumi
Okuse, Chiaki
Takaguchi, Koichi
Okada, Mitsuru
Okita, Kiwamu
HEPATOLOGY RESEARCH, 2014, 44 (01) : 73 - 82
[45] A randomized, multicenter, double-blind, placebo-controlled phase 2 trial of ISA247 in patients with chronic plaque psoriasis
Bissonnette, R
Papp, K
Poulin, Y
Lauzon, G
Aspeslet, L
Huizinga, R
Mayo, P
Foster, RT
Yatscoff, RW
Maksymowych, WP
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (03) : 472 - 478
[46] Fulranumab as Adjunctive Therapy for Cancer-Related Pain: A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study
Slatkin, Neal
Zaki, Naim
Wang, Steven
Louie, John
Sanga, Panna
Kelly, Kathleen M.
Thipphawong, John
JOURNAL OF PAIN, 2019, 20 (04): : 440 - 452
[47] Safety of efalizumab in patients with psoriatic arthritis: Results of a phase II, randomized, double-blind, placebo-controlled study
Papp, K
Mease, P
Garovoy, M
Zhang, D
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (03) : P156 - P156
[48] Results from PIONEER: A randomized, double-blind, placebo-controlled, phase 2 study of avapritinib in patients with indolent systemic mastocytosis (ISM)
Maurer, M.
Elberink, H. O.
Gotlib, J.
Sabato, V.
Hartmann, K.
Broesby-Olsen, S.
Castells, M.
Deininger, M. W.
Heaney, M. L.
George, T. I.
Siebenhaar, F.
Radia, D.
Triggiani, M.
van Daele, P.
Deangelo, D. J.
Schmidt-Kittler, O.
Lin, H. -M.
Morrison, A.
Mar, B.
Akin, C.
ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 77 - 77
[49] Efficacy and Safety of Omilancor in a Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Crohn's Disease
Chowla, Navreet M.
Tariq, Raseen
Aggarwal, Manik
Loftus, Edward V.
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S820 - S821
[50] Disease Characteristics of Acute Hepatic Porphyria Patients: ENVISION, a Phase 3 Global, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
Anderson, Karl
Balwani, Manisha
Sardh, Eliane
Gouya, Laurent
Rees, David
Stein, Penelope
Stolzel, Ulrich
Aguilera, Paula
Bissell, D. Montgomery
Bonkovsky, Herbert
Keel, Sioban
Parker, Charles
Phillips, John
Silver, Samuel
Windyga, Jerzy
D'Avola, Delia
Ross, Gayle
Stewart, Peter
Ritchie, Bruce
Oh, Jeeyoung
Harper, Pauline
Wang, Jiaan-Der
Langendonk, Janneke
Ivanova, Aneta
Horie, Yutaka
Minder, Elisabeth
Vassiliou, Daphne
Kubisch, Ilja
Guillen-Navarro, Encarna
Coman, David
Wang, Bruce
Kuo, Hung-Chou
Scalera, Sushama
Penz, Craig
Hua, Zoe
Simon, Amy
Ko, John J.
Ventura, Paolo
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S578 - S578

← 1 2 3 4 5 →